Fig. 7
Percentage of cell viability nanoformulations of VC-loaded in TCs-HA and pure VC-treated PC3 and HPrEc at a different concentration (mean ± SD, p ≤ 0.05, *** highly significant)
Fig. 7 | Cancer Nanotechnology
Percentage of cell viability nanoformulations of VC-loaded in TCs-HA and pure VC-treated PC3 and HPrEc at a different concentration (mean ± SD, p ≤ 0.05, *** highly significant)